It was unknown what protein mediated the antimalarial activity of the benzoxaborole AN3661; identifying PfCPSF3 as the direct target established both the drug's mechanism and a functional role for this protein in pre-mRNA 3′-end processing.
Evidence In vitro resistance selection with CRISPR-Cas9 active-site mutagenesis, homology modelling, and transcript analysis in wild-type versus resistant parasites
- No direct enzymatic reconstitution of PfCPSF3 endonuclease activity
- Interaction with other CPSF subunits or the broader 3′-end processing machinery not mapped
- AN3661 binding mode inferred from homology modelling rather than an experimental structure